bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Apr 04, 2016 9:19am EDT

bioAffinity Technologies Appoints New Science Team

Dec 14, 2015 1:00pm EST

bioAffinity Technologies Announces Patent Award in China

Dec 09, 2015 10:00am EST

bioAffinity Technologies Announces Novel Cancer Bio-label Presented at ASCB Annual Meeting

Oct 15, 2015 2:00pm EDT

bioAffinity Technologies Presents at McDermott Pharmaceutical/Medtech Dealmaking Symposium

Oct 07, 2015 1:04pm EDT

bioAffinity Technologies Welcomes New Board Members

Sep 30, 2015 4:26pm EDT

bioAffinity Technologies, UT Health Science Center San Antonio Announce Collaboration to Advance Non-Invasive Cancer Diagnostic

Sep 23, 2015 12:42pm EDT

Clinical Study for Non-Invasive Lung Cancer Test Reports Promising Results in Journal of Thoracic Oncology

  • arrow_back
  • 1…
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed


Phone

(210) 698-5334



Email

info@bioaffinitytech.com



LinkedIn

…/bioaffinitytechnologies



Twitter

@bioAffinity

Subscribe for News from bioAffinity Technologies

Subscribe
Copyright © 2023 bioAffinity Technologies, Inc.